Unusual 11 Mid-Day Movers 11/8: SGY) (OSIR) (ACAD) Higher; (BIOS) (OMF) (HTZ) Lower

November 8, 2016 1:01 PM EST

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

BioScrip (Nasdaq: BIOS) 46.5% LOWER; reported Q3 EPS of ($0.12), $0.07 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $224.5 million versus the consensus estimate of $223.26 million.

OneMain Holdings (NYSE: OMF) 38.9% LOWER; reported Q3 EPS of $0.90, may not compare to the analyst estimate of $1.07.

Hertz Global (NYSE: HTZ) 32.0% LOWER; reported Q3 EPS of $1.58, $1.17 worse than the analyst estimate of $2.75. Revenue for the quarter came in at $2.5 billion versus the consensus estimate of $2.6 billion. Hertz Global sees FY2016 EPS of $0.51-$0.88, versus the consensus of $2.94.

Kindred Healthcare (NYSE: KND) 30.9% LOWER; reported Q3 EPS of $0.05, $0.01 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $1.79 billion versus the consensus estimate of $1.77 billion. Kindred Healthcare sees FY2016 EPS of $0.70-$0.80, versus the consensus of $0.90. Kindred Healthcare sees FY2016 revenue of $7.2-7.3 billion, versus the consensus of $7.22 billion.

Rockwell Medical Technologies (Nasdaq: RMTI) 30.0% LOWER; reported Q3 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $12.8 million versus the consensus estimate of $15.4 million.

Stone Energy (NYSE: SGY) 29.3% HIGHER; reported Q3 EPS of ($7.40), $7.39 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $94.43 million versus the consensus estimate of $32.17 million.

Osiris Therapeutics, Inc. (Nasdaq: OSIR) 28.5% HIGHER; announced its preliminary revenue estimates for 2014 and 2015 and its anticipated 2016 revenue. As previously announced, the Company is working diligently to complete the restatement of its 2014 financial statements as soon as possible. Once that process is complete, the Company expects to transition to a new independent registered accounting firm and begin work on the 2015 financial statements. The Company has made substantial progress in its work on the restatement and as a result, the Company is now able to provide revenue estimates for these annual periods.

Acadia Pharma (Nasdaq: ACAD) 19.2% HIGHER; reported Q3 EPS of ($0.61), $0.05 worse than the analyst estimate of ($0.56). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $2.9 million.

Celldex (Nasdaq: CLDX) 18.1% HIGHER; reported Q3 EPS of ($0.29), $0.04 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $850 thousand.

Resolute Energy (NYSE: REN) 16.4% HIGHER; reported Q3 EPS of ($1.24), which may not compare with the analyst estimate of $0.29. Revenue for the quarter came in at $47.42 million versus the consensus estimate of $62.91 million. Adjusted EBITDA was $40.3 million, versus $30.8 million posted in the same period last year.

Addus HomeCare (Nasdaq: ADUS) 14.2% HIGHER; reported Q3 EPS of $0.23, $0.08 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $103.5 million versus the consensus estimate of $101.9 million.

To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Special Reports

Related Entities

Unusual 11 Mid-Day Movers

Add Your Comment